- (Rezulin),
withdrawn due to
increased incidence of drug-induced hepatitis.
Balaglitazone (DRF-2593) –
developed by Dr Reddy's Laboratories,
discontinued during...
- 15-Deoxy-Δ12,14-prostaglandin J2 15-HETE 15-HpETE
Aleglitazar Arachidonic acid
Balaglitazone Berberine Bezafibrate Cannabidiol Cevoglitazar Chiglitazar Ciglitazone...
- 15-Deoxy-Δ12,14-prostaglandin J2 15-HETE 15-HpETE
Aleglitazar Arachidonic acid
Balaglitazone Berberine Bezafibrate Cannabidiol Cevoglitazar Chiglitazar Ciglitazone...
- 15-Deoxy-Δ12,14-prostaglandin J2 15-HETE 15-HpETE
Aleglitazar Arachidonic acid
Balaglitazone Berberine Bezafibrate Cannabidiol Cevoglitazar Chiglitazar Ciglitazone...
- 15-Deoxy-Δ12,14-prostaglandin J2 15-HETE 15-HpETE
Aleglitazar Arachidonic acid
Balaglitazone Berberine Bezafibrate Cannabidiol Cevoglitazar Chiglitazar Ciglitazone...
-
Rheoscience A/S of
Denmark for the
joint development and
commercialisation of
Balaglitazone (DRF-2593), a
molecule for the
treatment of type-2 diabetes. Rheoscience...
- 15-Deoxy-Δ12,14-prostaglandin J2 15-HETE 15-HpETE
Aleglitazar Arachidonic acid
Balaglitazone Berberine Bezafibrate Cannabidiol Cevoglitazar Chiglitazar Ciglitazone...
- 15-Deoxy-Δ12,14-prostaglandin J2 15-HETE 15-HpETE
Aleglitazar Arachidonic acid
Balaglitazone Berberine Bezafibrate Cannabidiol Cevoglitazar Chiglitazar Ciglitazone...
- 15-Deoxy-Δ12,14-prostaglandin J2 15-HETE 15-HpETE
Aleglitazar Arachidonic acid
Balaglitazone Berberine Bezafibrate Cannabidiol Cevoglitazar Chiglitazar Ciglitazone...
- 15-Deoxy-Δ12,14-prostaglandin J2 15-HETE 15-HpETE
Aleglitazar Arachidonic acid
Balaglitazone Berberine Bezafibrate Cannabidiol Cevoglitazar Chiglitazar Ciglitazone...
